CD274 and neoplasm: Finally, the argument is sometimes made that the results of biomarker testing on an initial diagnostic specimen might be irrelevant as disease advances and the tumour evolves, developing new genomic alterations and changing its response to immune attack as evidenced by expression of PD-L1.